Skip to content
CFTR modulators: Monitoring and managing lung disease in real-life practice
Date: 15 April 2021
Speaker: Dr Uroš Krivec
Thank you for attending this CFTR modulator webinar.
*
Q1.
Please indicate how you feel regarding the following statement:
“The webinar session will be useful in supporting my everyday practice”
(Required.)
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
*
Q2.
To what extent did this webinar meet your expectations?
(Required.)
Exceeded my expectations
Met my expectations
Did not meet my expectations
*
Q3.
How would you rate the platform used to host the webinar?
(Required.)
Excellent
Very Good
Good
Fair
Poor
*
Q4.
How would you rate the communications around the webinar (invitations, reminder emails, local representative)?
(Required.)
Excellent
Very good
Good
Fair
Poor
*
Q5.
Which of the following topics would you like to see covered in future webinars (please select all that apply)?
(Required.)
Pulmonary function data
Real-life experience and clinical cases
Management of adverse events and drug-drug interactions
Quality of life and disease burden management
Adherence of CF patients
Early initiation of CFTR modulator therapies
Practicalities of initiating CFTR modulators
CFTR modulator clinical data
Q6.
Please provide any general comments on this meeting (logistics, platform, communication, support, speaker, etc.) and any suggestions of additional topics that you would like to see covered in future webinars.
Thank you for completing this feedback form.
We look forward to your attendance at future webinars.
CFTR, cystic fibrosis transmembrane conductance regulator.
This material is intended exclusively for healthcare professionals. Please do not forward.
BG-20-2100022, CF-096-03/2021, 196_CF_04/2021, SI-CF-2021-37, CRO-CF-2021-33, BG-CF-026-03/2021 I April 2021
